Head and Neck cancer Market Is Expected To Grow During The Forecast Period (2019-2032), DelveInsight | Key Companies – Merck, Bristol-Myers Squibb, Eli Lilly and Company, and others

April 06 23:52 2022
Head and Neck cancer Market Is Expected To Grow During The Forecast Period (2019-2032), DelveInsight | Key Companies - Merck, Bristol-Myers Squibb, Eli Lilly and Company, and others

DelveInsight’s Head and Neck Cancer Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Head and Neck cancer Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).


The Head and Neck Cancer Market report covers emerging drugs, current treatment practices, market share of the individual therapies, and the current forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.


Head and Neck cancer: Overview

Squamous cell carcinoma is cancer that arises from particular cells called squamous cells. Squamous cells are found in the outer layer of skin and in the mucous membranes, which are the moist tissues that line body cavities such as the airways and intestines. Head and Neck Squamous Cell Carcinoma (HNSCC) develops in the mucous membranes of the mouth, nose, and throat.


Some of the key facts of the Head and Neck Cancer Market Report

  • Head and Neck Squamous Cell Carcinoma (HNSCC) is slightly more common in women than in men.
  • Head and Neck Squamous Cell Carcinoma (HNSCC) is the seventh most common cancer worldwide. Approximately 600,000 new cases are diagnosed each year, including about 50,000 in the United States. HNSCC occurs most often in men in their 50s or 60s, although the incidence among younger individuals is increasing.
  • According to a study, In the United States, more than 54 000 new cases were diagnosed in 2014, resulting in an annual incidence of 15 per 100 000, with 12 000 deaths attributed to the disease.


Head and Neck Cancer Market

The Head and Neck cancer Market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of the Head and Neck cancer Market in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Head and Neck cancer Market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Head and Neck cancer Market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.


Head and Neck Cancer Market Insights

Cancers of the head and neck are more common today than ever due to the association with the human papillomavirus (HPV) infection, making up 50,000 new cases a year in the United States. Improvement in outcomes are needed for patients with recurrent and or metastatic squamous cell carcinoma of the head and neck (HNSCC).


Head and Neck Cancer Treatment Market

The main treatment options are:

  • Surgery
  • Radiation therapy
  • Chemotherapy
  • and targeted therapy


Head and Neck Cancer Epidemiology

The epidemiology section covers insights into the historical and current Head and Neck cancer Market patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.


Head and Neck cancer Market Drugs & Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Head and Neck cancer Market or expected to get launched in the market during the study period. The analysis covers Head and Neck cancer market uptake by drugs; patient uptake by therapies; and sales of each drug.

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Head and Neck cancer Market Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.


Head and Neck cancer Emerging Therapies

Ongoing clinical trials are investigating a number of potential drugs for the treatment of HNSCC. The research and development of new treatment therapies for HNSCC are categorized into various groups. The dynamics of HNSCC market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and also the expected launch of emerging therapies such as PDS0101 (PDS Biotechnology Corporation), LN-145 (Iovance Biotherapeutics), CUE-101 (CueBio), Tipifarnib (Kura Oncology), (Afatinib or BIBW2992) Boehringer Ingelheim and others during the forecast period.


Head and Neck cancer Market Companies

  • Merck
  • Bristol-Myers Squibb
  • Eli Lilly and Company, and others


Head and Neck cancer Market Drugs

  • Keytruda
  • Opdivo
  • Erbitux
  • Opdivo, and others


Read Full Research Report @ https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market  


Table of content

  1. Key Insights
  2. Executive Summary
  3. Competitive Intelligence Analysis
  4. Market Overview at a Glance
  5. Disease Background and Overview
  6. Patient Journey
  7. Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Head and Neck cancer Market Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight


Consult with our Business Expert @ https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market


About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/